Risk Factors and Response to Therapy in Heart and Lung Transplant Patients with Posttransplant Lymphoproliferative Disease

Not Applicable

Completed

• Conditions: Posttransplant Lymphoproliferative Disease; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma

• Registration Number: ACTRN12613001094763
• Lead Sponsor: John Moore

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Heart and Lung transplant patients who were transplanted at St Vincent's Hospital, Sydney from the commencement of the transplant program until 2013.
Posttransplant lymphoproliferative disease was an inclusion criteria. No other malignant diseases were elligible.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified